跳至主要内容
临床试验/NCT00531414
NCT00531414已完成不适用

Inspiratory Flow and VOlumes in Asthmatic and Healthy Individuals Using the Osmohaler

Syntara0 个研究点目标入组 30 人开始时间: 2007年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30

研究概览

简要总结

The OsmohalerTM is a registered device in Australia. It is used to deliver a dry powder a commercial preparation of mannitol registered as AridolTM to test if a person has irritable airways such as active asthma.

The overseas regulatory authorities need to know that people of all ages can achieve an adequate inspiratory flow through this device during a controlled deep inspiration. Adequate flow is generally regarded as greater than 30 litres per minute in children and 60 litres per minute in adults. The OsmohalerTM is a device with low resistance and is already in use in Australia to deliver mannitol. However there is a need to document inspiratory flows through the device during a controlled deep inspiration. The protocol requires subjects to perform a controlled deep inspiration from the device on three or five occasions. No substance will be inhaled.

研究设计

研究类型
Observational
时间视角
Prospective

入排标准

年龄范围
6 Years 至 69 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • has asthma or is healthy
  • aged 6 to 69 years inclusive
  • FEV1 >/= 70% predicted

排除标准

  • has condition contraindicating performance of spirometrt

研究者

发起方
Syntara
申办方类型
Industry

相似试验